Equibles does not estimate personal net worth.
Get an email with a short summary when Senseonics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get SENS alertsMukul Jain is recorded as CTO and COO at Senseonics Holdings, Inc. (SENS). The newest filing on record that lists Mukul Jain as COO at Senseonics Holdings, Inc. (SENS) is dated April 6, 2026. The proxy statement of Senseonics Holdings, Inc. reports total compensation of $1,945,166 for Mukul Jain in fiscal 2025, including a base salary of $511,000. Disclosed compensation is on record for 8 fiscal years. Mukul Jain has spoken on 5 earnings calls across 1 company, most recently for Senseonics Holdings, Inc. on August 6, 2026. Senseonics Holdings, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Senseonics Holdings, Inc. includes Timothy T. Goodnow (CEO and Board Member), Frederick ("Rick") Sullivan (CFO), Jon D. Isaacson (CFO) and 6 others.
“So, that should be our expectation to see it by next summer. We will complete end of the year, submit Q1, and then a 510K submission, followed by hopefully within a quarter of that.”
“So what would be similar would be the evaluation, right, where we bring the patients to the clinic and hook them up and do a bedside monitoring of that accuracy to YSI while we look at the glucose data coming out of the CGM and compare the two.”
“Yes, so it's, as we had previously stated, a 510-K. So there is a certain timeline that FDA adheres to. Our confidence comes from our past interactions and the relationship we have with the agency and the quality of the data that we have submitted.”
“Hey Jason, yeah, so we are thinking in the first half, there will be some dependency on when we hear back on the other submission that's in active review right now.”
“Yes, we are very much on track to finish up the ICGM, but patient data has been completed, and the clinical team is cleaning up data. We expect it to be in front of the FDA in the coming months.”
Start not stated–present
Last confirmed April 6, 2026
Medical Devices · Healthcare
CTO, COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $511,000 | $1,945,166 |
| 2024 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $492,960 | $1,892,920 |
| 2023 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $474,000 | $1,785,242 |
| 2022 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $453,000 | $1,719,847 |
| 2021 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $439,810 | $1,419,746 |
| 2020 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $427,000 | $1,593,479 |
| 2019 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $414,750 | $1,403,605 |
| 2018 | Senseonics Holdings, Inc. (SENS) | Chief Operating Officer | $395,000 | $1,383,625 |
